Evening primrose oil capsules

This product contains rich g-linolenic acid (GLA), which can be converted into PEG2, PGI2, and PGF2a, and has obvious lipid-lowering and anti-platelet aggregation effects. G-linolenic acid has obvious cholesterol-lowering effect, and its efficacy is 163 times that of linoleic acid. Evening primrose oil can reduce serum total cholesterol, low-density lipoprotein cholesterol, and very low-density lipoprotein cholesterol in hyperlipidemic rats, and significantly increase the level of high-density cholesterol. The change in high-density lipoprotein cholesterol is due to the increase in the cholesterol level of high-density lipoprotein subfractions, and there is no significant change in the cholesterol level outside the high-density lipoprotein subfractions. Wistar rats were gavaged with hyperlipidemic modeling agents or ethylsulfate to create a hyperlipidemia pathological model. The results showed that evening primrose oil and its sodium salt have strong lipid-lowering and anti-atherosclerotic effects. This product can participate in the synthesis and balance of prostaglandins. It can also significantly inhibit platelet aggregation and the synthesis of thromboxane A2 (TXA2) by platelets, thereby changing the ratio of TXA2/PGI2, and has the effect of preventing and treating thrombotic cardiovascular diseases. G-linolenic acid stimulates brown adipose tissue, promotes the activity of brown fatty acid mitochondria, consumes excess calories and achieves a certain weight loss effect.

The main ingredient of this product is γ-linolenic acid (GLA), and its chemical name is: all-cis-6,9,12-octadecatrienoic acid.

This product is a capsule, and the content is a light yellow to orange-yellow oily liquid.

It is used to prevent and treat arteriosclerosis, lower blood lipids, etc.

Oral administration: 5-6 capsules at a time, twice a day, or as directed by your doctor.

Some patients may experience adverse reactions such as nausea and loose stools in the early stages of oral medication, but these reactions may improve with continued medication.

1. It is contraindicated for those who are allergic to this product. It is contraindicated for patients with hemorrhagic diseases. It is contraindicated for pregnant women. 2. It is contraindicated for those who have severe cardiovascular disease or cerebrovascular accident recently. Take a short rest after taking the medicine to prevent postural hypotension. Individuals with palpitations or premature heart beats should stop taking the medicine.

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: Pregnant women are prohibited. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.

This experiment has not been conducted and there are no reliable references.

Keep away from light, sealed and stored in a dry place.

0.3g (calculated as evening primrose oil)

18 months

Changchun Norman Bethune Pharmaceutical Co., Ltd.

• Founded in:

  1985-12-06

• Address:

  No. 358, Chuangxin Road, High-tech Industrial Development Zone, Changchun City, Jilin Province

• Tax NO.:

  91220101123997525C

• Registered Funds:

  64.4778 million yuan

• Website:

  Log in to view

• Email:

  Log in to view